Rein Therapeutics, Inc. (RNTX) SEC filings
RNTX SEC filings moved a median of -0.49% by the close. RNTX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the RNTX overview →
47 measured RNTX SEC filing events.
Where these RNTX SEC filings landedvs 46 measured RNTX SEC filing reactions
| Middle 50% of RNTX SEC filing reactions | -3.77% to +4.05% |
|---|---|
| Median reaction (to close) | -0.49% |
| Measured reactions | 46 |
Point-in-time · zero look-ahead
Half of the 46 RNTX SEC filing events with a measured close landed between -3.77% and +4.05%; 43% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Rein Therapeutics, Inc. For: Sep 04 | SEC filing · Form 8-K | -1.04% | -7.26% | |
| Form 8-K Rein Therapeutics, Inc. For: Aug 21 | SEC filing · Form 8-K | -0.88% | -3.34% | |
| Form 10-Q Rein Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.60% | -0.49% | |
| Form 8-K Rein Therapeutics, Inc. For: Jul 20 | SEC filing · Form 8-K | -1.00% | -6.67% | |
| Form ARS Rein Therapeutics, Inc. For: Dec 31 | SEC filing · Form ARS | -3.41% | -0.70% | |
| Form DEF 14A Rein Therapeutics, Inc. For: Jul 20 | SEC filing · Form DEF | -3.41% | -0.70% | |
| Form DEFA14A Rein Therapeutics, Inc. | SEC filing · Form DEFA14A | -3.41% | -0.70% | |
| Form PRE 14A Rein Therapeutics, Inc. For: Jul 20 | SEC filing · Form PRE | +2.70% | +0.00% | |
| Form 10-Q Rein Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.91% | -4.54% | |
| Form 8-K Rein Therapeutics, Inc. For: Apr 30 | SEC filing · Form 8-K | -1.43% | -2.86% | |
| Form EFFECT Rein Therapeutics, Inc. | SEC filing · Form EFFECT | +0.48% | -0.48% | |
| Form S-1 Rein Therapeutics, Inc. | SEC filing · Form S-1 | -0.78% | -1.16% | |
| Form 10-K/A Rein Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | -9.15% | |
| Form 10-K Rein Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | -7.21% | +0.81% | |
| Form 8-K Rein Therapeutics, Inc. For: Feb 24 | SEC filing · Form 8-K | +0.00% | +2.59% | |
| Form 8-K Rein Therapeutics, Inc. For: Feb 16 | SEC filing · Form 8-K | +0.00% | +11.01% | |
| Form 8-K Rein Therapeutics, Inc. For: Jan 15 | SEC filing · Form 8-K | +4.26% | +7.14% | |
| Form 8-K Rein Therapeutics, Inc. For: Dec 11 | SEC filing · Form 8-K | +0.00% | +1.31% | |
| Form 10-Q Rein Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -2.42% | +0.81% | |
| Form 8-K Rein Therapeutics, Inc. For: Nov 03 | SEC filing · Form 8-K | -1.48% | +3.55% | |
| Form 8-K Rein Therapeutics, Inc. For: Oct 23 | SEC filing · Form 8-K | +1.98% | -9.40% | |
| Form 8-K Rein Therapeutics, Inc. For: Oct 09 | SEC filing · Form 8-K | -2.88% | -1.44% | |
| Form 8-K Rein Therapeutics, Inc. For: Sep 16 | SEC filing · Form 8-K | +0.83% | -2.48% | |
| Form 8-K Rein Therapeutics, Inc. For: Sep 08 | SEC filing · Form 8-K | -1.51% | -0.76% | |
| Form EFFECT Rein Therapeutics, Inc. | SEC filing · Form EFFECT | +0.00% | +0.00% | |
| Form S-1 Rein Therapeutics, Inc. | SEC filing · Form S-1 | +4.84% | +10.08% | |
| Form 8-K Rein Therapeutics, Inc. For: Aug 19 | SEC filing · Form 8-K | -2.50% | — | |
| Form 10-Q Rein Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.87% | +3.83% | |
| Form 8-K Rein Therapeutics, Inc. For: Jul 29 | SEC filing · Form 8-K | — | -5.93% | |
| Form 8-K Rein Therapeutics, Inc. For: Jul 23 | SEC filing · Form 8-K | +0.00% | -8.39% | |
| Form 8-K Rein Therapeutics, Inc. For: Jul 08 | SEC filing · Form 8-K | — | +7.14% | |
| Form DEFA14A Rein Therapeutics, Inc. | SEC filing · Form DEFA14A | — | +7.14% | |
| Form 8-K Rein Therapeutics, Inc. For: Jun 24 | SEC filing · Form 8-K | — | +4.05% | |
| Form DEFA14A Rein Therapeutics, Inc. | SEC filing · Form DEFA14A | — | +4.05% | |
| Form 8-K Rein Therapeutics, Inc. For: Jun 10 | SEC filing · Form 8-K | +0.00% | +4.44% | |
| Form EFFECT Rein Therapeutics, Inc. | SEC filing · Form EFFECT | +0.00% | +7.33% | |
| Form S-3 Rein Therapeutics, Inc. | SEC filing · Form S-3 | +0.00% | -3.91% | |
| Form 10-Q Rein Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -3.91% | |
| Form 8-K Rein Therapeutics, Inc. For: May 15 | SEC filing · Form 8-K | +0.00% | -3.91% | |
| Form ARS Rein Therapeutics, Inc. For: Dec 31 | SEC filing · Form ARS | +1.96% | +9.50% | |
| Form DEF 14A Rein Therapeutics, Inc. For: Jun 24 | SEC filing · Form DEF | +1.96% | +9.50% | |
| Form DEFA14A Rein Therapeutics, Inc. | SEC filing · Form DEFA14A | +1.96% | +9.50% | |
| Form 10-K/A Rein Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | — | -8.89% | |
| Form 8-K Rein Therapeutics, Inc. For: Apr 21 | SEC filing · Form 8-K | +0.00% | +1.09% | |
| Form 8-K Rein Therapeutics, Inc. For: Apr 16 | SEC filing · Form 8-K | +0.00% | +7.88% | |
| Form 10-K Rein Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | -19.19% | |
| Form NT 10-K Rein Therapeutics, Inc. For: Dec 31 | SEC filing · Form NT | — | -1.69% |
Keep exploring
More RNTX: earnings → · analyst actions → · RNTX overview →